ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so its customers can move ahead with confidence. With nearly 50 years experience, ERT balances knowledge of what works with a vision for what’s next. In 2017, ERT supported more than 60% of all FDA drug approvals. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly ─ and with confidence.